Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
The Company is invited to attend an institutional investor conference hosted by President Securities on September 27, 2022.
2022-09-26
Announcement of the BOD approved removal of the non-compete clause for directors on behalf of major subsidiary Excelsior Asset Management Co., Ltd.
2022-09-06
Announcement of the resolution by the BOD for the ex-rights and record date of stock dividends on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
2022-09-06
Announcement of the important resolutions made by Board of Directors on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
2022-09-06
Announcement of the Board of Directors on election of Chairperson on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
2022-09-02
Announcement of change in representative of institutional director and supervisor on behalf of major subsidiary,Excelsior Asset Management Co., Ltd.
2022-09-02
Announcement of the decision by the Company for the ex-rights record date of stock dividends.
2022-08-12
The Board of Directors release the prohibition on managers from participation in competition businesses.
2022-08-04
Announcement about the apponitment of Corporate Governance Officer
2022-08-04
The Board of Directors approved Q2 2022 consolidated financial statements.
2022-08-04
